Skip to main content

Table 1 Quality assessment of included studies

From: The role of 18F-FDG PET/MRI in assessing pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: a systematic review and meta-analysis

Author (Reference)

Selection

Comparability

Outcome

Overall score

Representativeness of the exposed cohort

Selection of the non-exposed cohort

Ascertainment of exposure

Demonstration that outcome of interest was not present at the start of the study

Comparability of cohorts based on the design or analysis

Assessment of outcome

Was follow-up long enough for outcomes to occur

Adequacy of follow-up of cohorts

Sekine [11]

*

*

*

*

**

*

*

*

9

Cho

[13]

*

*

*

 

**

*

*

*

8

de Mooij [14]

*

*

*

   

*

*

5

Wang

[15]

*

*

*

 

**

*

*

*

8

de Mooij [16]

*

*

*

 

**

*

 

*

7

Umutlu

[12]

  

*

*

**

*

 

*

6